0001213900-24-111563.txt : 20241223 0001213900-24-111563.hdr.sgml : 20241223 20241223092414 ACCESSION NUMBER: 0001213900-24-111563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241220 FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOUDENBERG MICHAEL CENTRAL INDEX KEY: 0001817884 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 241570341 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 4 1 ownership.xml X0508 4 2024-12-20 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817884 WOUDENBERG MICHAEL C/O INMED PHARMACEUTICALS INC. 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C3E8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Operating Officer 0 Employee Stock Option (Right to Buy) 4.14 2024-12-20 4 A 0 3750 0.00 A 2029-12-19 Common shares 3750 7505 D The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month). On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split. /s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg 2024-12-23